InterCure Ltd. (INCR)
NASDAQ: INCR · Real-Time Price · USD
1.040
+0.010 (0.97%)
At close: Jun 26, 2026, 4:00 PM EDT
1.010
-0.030 (-2.88%)
After-hours: Jun 26, 2026, 6:26 PM EDT
Company Description
InterCure Ltd., together with its subsidiaries, engages in the production, manufacturing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally.
The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector.
The company was incorporated in 1994 and is headquartered in Herzliya, Israel.
InterCure Ltd.
| Country | Israel |
| Founded | 1994 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 285 |
| CEO | Alexander Rabinovich |
Contact Details
Address: 85 Medinat ha-Yehudim Street Herzliya, 4676670 Israel | |
| Phone | 972 7 746 05012 |
| Website | intercure.co |
Stock Details
| Ticker Symbol | INCR |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | ILS |
| IPO Price | $0.00 |
| CIK Code | 0001857030 |
| CUSIP Number | M549GJ111 |
| ISIN Number | IL0011063760 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Alexander Rabinovich | Chief Executive Officer and Chairman |
| Amos Cohen | Chief Financial Officer |
| Einat Zehavi | Vice President of Sales |
| Itai Kabiljo | General Counsel |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 22, 2026 | 6-K | Report of foreign issuer |
| Jun 15, 2026 | 6-K | Report of foreign issuer |
| May 1, 2026 | 6-K | Report of foreign issuer |
| Apr 30, 2026 | 20-F | Annual and transition report of foreign private issuers |
| Mar 3, 2026 | 6-K | Report of foreign issuer |
| Feb 19, 2026 | 6-K | Report of foreign issuer |
| Dec 30, 2025 | 6-K | Report of foreign issuer |
| Dec 18, 2025 | 6-K | Report of foreign issuer |
| Dec 9, 2025 | SCHEDULE 13D | Filing |
| Nov 25, 2025 | 6-K | Report of foreign issuer |